Clinical

The AJMC^® clinical page includes all the published content across AJMC.com, The American Journal of Managed Care^® and Evidence-Based Oncology™ on a variety of specialties, including dermatology, cardiology, oncology, and rheumatology.

Latest News

Ovarian cancer | Image Credit: tashatuvango - stock.adobe.com

Final PICCOLO Data Highlight Efficacy of Mirvetuximab Soravtansine in Later-Line Frα+ Platinum-Sensitive Ovarian Cancer

June 27th 2025

Mirvetuximab soravtansine continues to show efficacy and safety in the final analysis of the phase 2 PICCOLO study.

Hemophilia | Image credit: jarun011 - stock.adobe.com

Marstacimab Improved Key Bleeding Outcomes in Hemophilia A or B

By Julia Bonavitacola

June 26th 2025

3D illustration of ovarian cancer | Image Credit: Dr_Microbe - stock.adobe.com

First-Line Rucaparib Maintenance Reduces Progression Risk Across Prognostic Subgroups in HRD– High-Grade Ovarian Cancer

June 25th 2025

Marginal zone lymphoma | Image: Atlas of Hematological Cytology

In R/R Marginal Zone Lymphoma, 90% Alive at 2 Years After Liso-Cel

By Mary Caffrey

June 24th 2025

Myasthenia gravis diagnosis | Image Credit: Maggie L. Shaw/sora.chatgpt.com

RemeGen’s Telitacicept Gains China Approval for Myasthenia Gravis

By Abigail Lewis

June 19th 2025

More News

Impact of Cost on Patients' Access to Treatment

Impact of Cost on Patients' Access to Treatment

Watch

How Drug Cost Influences Drug Selection

How Drug Cost Influences Drug Selection

Watch

Role of Early Intervention in Preventing Progression to T2D

Role of Early Intervention in Preventing Progression to T2D

Watch

Major Cost Drivers in T2D Management

Major Cost Drivers in T2D Management

Watch

Updates to Treatment Guidelines: Effects on Payers

Updates to Treatment Guidelines: Effects on Payers

Watch

Advantages of Medications that Treat Multiple Conditions

Advantages of Medications that Treat Multiple Conditions

Watch

Management of Hyperlipidemia in Patients With Liver Impairment or Renal Impairment

Management of Hyperlipidemia in Patients With Liver Impairment or Renal Impairment

Watch

Considerations Regarding Statin Therapy

Considerations Regarding Statin Therapy

Watch

Role of Clinical Practice Guidelines in the Management of Diabetes and Diabetes-Related Complications

Role of Clinical Practice Guidelines in the Management of Diabetes and Diabetes-Related Complications

Watch

Addressing the Effect of Polypharmacy on Medication Adherence

Addressing the Effect of Polypharmacy on Medication Adherence

Watch

The Role of Managed Care in Identifying and Counseling Patients With Prediabetes

The Role of Managed Care in Identifying and Counseling Patients With Prediabetes

Watch

Partnering With Providers to Prevent or Delay Complications Related to Diabetes

Partnering With Providers to Prevent or Delay Complications Related to Diabetes

Watch

WellCare's Initiatives To Improve Care for Members With Diabetes

WellCare's Initiatives To Improve Care for Members With Diabetes

Watch

Alternatives to Add-On Therapy for T2D and Hyperlipidemia

Alternatives to Add-On Therapy for T2D and Hyperlipidemia

Watch

The Influence of Lipid Guidelines on Real-World Practice Patterns

The Influence of Lipid Guidelines on Real-World Practice Patterns

Watch

Variables Involved When Adding Medications to Treat Diabetes

Variables Involved When Adding Medications to Treat Diabetes

Watch

How Does the Potential for Weight Gain Influence Choice of Therapies?

How Does the Potential for Weight Gain Influence Choice of Therapies?

Watch

Comparison of Guidelines From ADA and AACE

Comparison of Guidelines From ADA and AACE

Watch

Complications of Diabetes and Role of Insulin Resistance in Metabolic Syndrome

Complications of Diabetes and Role of Insulin Resistance in Metabolic Syndrome

Watch

BMS Piqued by ICER's HTA Report on New Myeloma Drugs, Publishes Response

Surabhi Dangi-Garimella, PhD

Bristol-Myers Squibb has challenged the recently released report by the Institute for Clinical and Economic Review that evaluates the clinical and cost effectiveness of newer treatments for multiple myeloma.

Read More

"It Takes a Village" to Tackle the Diabetes Epidemic

"It Takes a Village" to Tackle the Diabetes Epidemic

Watch

What Is the Role of the Provider in Guiding People to Better Adherence?

What Is the Role of the Provider in Guiding People to Better Adherence?

Watch

Using Apps to Help Patients Manage Diabetes

Using Apps to Help Patients Manage Diabetes

Watch

How Can We Align Financing Incentives With Quality?

How Can We Align Financing Incentives With Quality?

Watch

Why Recent Clinical Trials Make This a "Very Exciting Time" in Diabetes Care

Why Recent Clinical Trials Make This a "Very Exciting Time" in Diabetes Care

Watch

Using Guidelines to Overcome Clinical Inertia

Using Guidelines to Overcome Clinical Inertia

Watch

The Pharmacist as a Member of the Managed Care Team

The Pharmacist as a Member of the Managed Care Team

Watch

Navigating the Evidence: From Clinical Trial to Clinical Practice

Navigating the Evidence: From Clinical Trial to Clinical Practice

Watch

Engaging the Community to Promote Population Health

Engaging the Community to Promote Population Health

Watch

The Patient-Centered Medical Home in Diabetes Care

The Patient-Centered Medical Home in Diabetes Care

Watch

...

245 246 247 248 249 250 251 252 253

...

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions